240 related articles for article (PubMed ID: 27029396)
1. Closure of Secundum Atrial Septal Defects by Using the Occlutech Occluder Devices in More Than 1300 Patients: The IRFACODE Project: A Retrospective Case Series.
Haas NA; Soetemann DB; Ates I; Baspinar O; Ditkivskyy I; Duke C; Godart F; Lorber A; Oliveira E; Onorato E; Pac F; Promphan W; Riede FT; Roymanee S; Sabiniewicz R; Shebani SO; Sievert H; Tin D; Happel CM
Catheter Cardiovasc Interv; 2016 Oct; 88(4):571-581. PubMed ID: 27029396
[TBL] [Abstract][Full Text] [Related]
2. Multicenter midterm follow-up results using the gore septal occluder for atrial septal defect closure in pediatric patients.
Grohmann J; Wildberg C; Zartner P; Abu-Tair T; Tarusinov G; Kitzmüller E; Schmoor C; Stiller B; Kampmann C
Catheter Cardiovasc Interv; 2017 Jun; 89(7):E226-E232. PubMed ID: 27900839
[TBL] [Abstract][Full Text] [Related]
3. Transcatheter closure of atrial septal defect with the Figulla(®) ASD Occluder: a comparative study with the Amplatzer(®) Septal Occluder.
Godart F; Houeijeh A; Recher M; Francart C; Polge AS; Richardson M; Cajot MA; Duhamel A
Arch Cardiovasc Dis; 2015 Jan; 108(1):57-63. PubMed ID: 25453168
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the Occlutech ® Figulla ® septal occluder and Amplatzer ® septal occluder for atrial septal defect device closure.
Roymanee S; Promphan W; Tonklang N; Wongwaitaweewong K
Pediatr Cardiol; 2015 Jun; 36(5):935-41. PubMed ID: 25633819
[TBL] [Abstract][Full Text] [Related]
5. A randomized, controlled, multi-center trial of the efficacy and safety of the Occlutech Figulla Flex-II Occluder compared to the Amplatzer Septal Occluder for transcatheter closure of secundum atrial septal defects.
Kenny D; Eicken A; Dähnert I; Boudjemline Y; Sievert H; Schneider MB; Gori T; Hijazi ZM;
Catheter Cardiovasc Interv; 2019 Feb; 93(2):316-321. PubMed ID: 30719850
[TBL] [Abstract][Full Text] [Related]
6. Mid-Term Outcomes after Percutaneous Closure of the Secundum Atrial Septal Defect with the Figulla-Occlutech Device.
Pedra CA; Pedra SF; Costa RN; Ribeiro MS; Nascimento W; Campanhã LO; Santana MV; Jatene IB; Assef JE; Fontes VF
J Interv Cardiol; 2016 Apr; 29(2):208-15. PubMed ID: 26927945
[TBL] [Abstract][Full Text] [Related]
7. Initial clinical experience with the GORE
de Hemptinne Q; Horlick EM; Osten MD; Millán X; Tadros VX; Pighi M; Gonzalez Barlatey F; Alnasser SM; Miró J; Asgar AW; Ibrahim R
Catheter Cardiovasc Interv; 2017 Sep; 90(3):495-503. PubMed ID: 28128523
[TBL] [Abstract][Full Text] [Related]
8. Transcatheter closure of atrial septal defects in children and adolescents: single-center experience with the GORE® septal occluder.
Grohmann J; Höhn R; Fleck T; Schmoor C; Stiller B
Catheter Cardiovasc Interv; 2014 Nov; 84(6):E51-7. PubMed ID: 24664494
[TBL] [Abstract][Full Text] [Related]
9. First experiences with the GORE(®) Septal Occluder in children and adults with atrial septal defects.
Nyboe C; Hjortdal VE; Nielsen-Kudsk JE
Catheter Cardiovasc Interv; 2013 Nov; 82(6):929-34. PubMed ID: 23404677
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of transcatheter closure in unselected patients with secundum atrial septal defect, using Amplatzer devices and a modified sizing balloon technique.
Kammache I; Mancini J; Ovaert C; Habib G; Fraisse A
Catheter Cardiovasc Interv; 2011 Nov; 78(5):665-74. PubMed ID: 21812090
[TBL] [Abstract][Full Text] [Related]
11. Clinical results of large secundum atrial septal defect closure in adult using percutaneous transcatheter Cocoon atrial septal occluder.
Lairakdomrong K; Srimahachota S; Lertsapcharoen P; Chaipromprasit J; Boonyaratavej S; Kaewsukkho P
J Med Assoc Thai; 2013 Sep; 96(9):1127-34. PubMed ID: 24163987
[TBL] [Abstract][Full Text] [Related]
12. Safety of Occlutech Septal Occluder ACCELL Flex II for Transcatheter Closure of Secundum Atrial Septal Defects in Children: A Long-Term Follow-Up.
El-Sisi AM; El-Saiedi SA; Ammar R; Abdelhameed A; Hijazi ZM; Soliman MM
J Interv Cardiol; 2022; 2022():8886813. PubMed ID: 35069039
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of the STARFlex device for closure of secundum atrial septal defect.
Law MA; Josey J; Justino H; Mullins CE; Ing FF; Nugent AW
Catheter Cardiovasc Interv; 2009 Feb; 73(2):190-5. PubMed ID: 19156887
[TBL] [Abstract][Full Text] [Related]
14. Early-mid term follow-up results of percutaneous closure of the interatrial septal defects with occlutech figulla devices: a single center experience.
Aytemir K; Oto A; Ozkutlu S; Kaya EB; Canpolat U; Yorgun H; Sahiner L; Kabakçi G
J Interv Cardiol; 2012 Aug; 25(4):375-81. PubMed ID: 22612236
[TBL] [Abstract][Full Text] [Related]
15. Immediate and short-term outcomes after percutaneous atrial septal defect closure using the new nit-occlud ASD-R device.
Peirone A; Contreras A; Ferrero A; da Costa RN; Pedra SF; Pedra CA
Catheter Cardiovasc Interv; 2014 Sep; 84(3):464-70. PubMed ID: 24677704
[TBL] [Abstract][Full Text] [Related]
16. Retrieval of large Occlutech Figula Flex septal defect occluders using a commercially available bioptome: proof of concept.
Georgiev S; Tanase D; Genz T; Ewert P; Naumann S; Pozza RD; Eicken A
Cardiol Young; 2018 Jul; 28(7):955-960. PubMed ID: 29779498
[TBL] [Abstract][Full Text] [Related]
17. Transcatheter interatrial septal defect closure in a large cohort: midterm follow-up results.
Aytemir K; Oto A; Özkutlu S; Canpolat U; Kaya EB; Yorgun H; Şahiner L; Sunman H; Ateş AH; Kabakçı G
Congenit Heart Dis; 2013; 8(5):418-27. PubMed ID: 23601507
[TBL] [Abstract][Full Text] [Related]
18. Device therapy for atrial septal defects in a multicenter cohort: acute outcomes and adverse events.
El-Said H; Hegde S; Foerster S; Hellenbrand W; Kreutzer J; Trucco SM; Holzer R; Burch G; Mirani A; Nicolas R; Porras D; Bergersen L; Moore J
Catheter Cardiovasc Interv; 2015 Feb; 85(2):227-33. PubMed ID: 25257700
[TBL] [Abstract][Full Text] [Related]
19. The influence of deficient retro-aortic rim on technical success and early adverse events following device closure of secundum atrial septal defects: An Analysis of the IMPACT Registry
O'Byrne ML; Gillespie MJ; Kennedy KF; Dori Y; Rome JJ; Glatz AC
Catheter Cardiovasc Interv; 2017 Jan; 89(1):102-111. PubMed ID: 27189502
[TBL] [Abstract][Full Text] [Related]
20. ASSURED clinical study: New GORE® CARDIOFORM ASD occluder for transcatheter closure of atrial septal defect.
Sommer RJ; Love BA; Paolillo JA; Gray RG; Goldstein BH; Morgan GJ; Gillespie MJ;
Catheter Cardiovasc Interv; 2020 Jun; 95(7):1285-1295. PubMed ID: 31943749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
